GlobalData on MSN6d
Nuvig secures $161m financing to support clinical studies for NVG-2089
Nuvig Therapeutics has closed a $161m Series B financing round to advance its preclinical pipeline and support NVG-2089’s ...
news.crunchbase6d
The Week’s Biggest Funding Rounds: Tenstorrent And Nuvig Top List
After a slow Thanksgiving week, investors made up for lost time with a slew of big-money rounds. VCs spread their cash around ...
The Pharma Letter6d
Sanofi sees potential in Nuvig’s novel approach
Nuvig Therapeutics raises $161 million in Series B funding to advance novel immunomodulatory treatments for autoimmune ...
pharmaphorum6d
Atlas closes $450m biotech fund, and other financing news
Investment group Atlas Ventures has closed its fourteenth fund, raising $450 million for the next round of investment in ...
Medpage Today on MSN3d
Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia
SAN DIEGO -- Treatment with an investigational oral inhibitor of Bruton's tyrosine kinase (BTK) was safe and boosted platelet ...
MM&M6d
Rx Rundown: Eli Lilly, Amgen, GSK and more
President-elect Donald Trump hosted the chief executives of Pfizer, Eli Lilly and PhRMA at Mar-a-Lago for a dinner with ...
clinicaltrialsarena6d
Nuvig secures $161m financing to support clinical studies for NVG-2089
Credit: Bangkok Click Studio/Shutterstock. Nuvig Therapeutics has closed a $161m Series B financing round to advance its preclinical pipeline and support NVG-2089’s clinical proof-of-concept trials.